Vertex Pharmaceuticals Inc (VRTX)
410.19
+7.69
(+1.91%)
USD |
NASDAQ |
May 07, 16:00
410.19
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash and Short Term Investments (Annual): 11.22B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.22B |
| December 31, 2022 | 10.78B |
| December 31, 2021 | 7.525B |
| December 31, 2020 | 6.659B |
| December 31, 2019 | 3.808B |
| December 31, 2018 | 3.168B |
| December 31, 2017 | 2.089B |
| December 31, 2016 | 1.435B |
| December 31, 2015 | 1.042B |
| December 31, 2014 | 1.387B |
| December 31, 2013 | 1.465B |
| December 31, 2012 | 1.321B |
| December 31, 2011 | 968.92M |
| December 31, 2010 | 1.031B |
| December 31, 2009 | 1.285B |
| December 31, 2008 | 832.10M |
| December 31, 2007 | 460.87M |
| Date | Value |
|---|---|
| December 31, 2006 | 704.63M |
| December 31, 2005 | 361.16M |
| December 31, 2004 | 386.25M |
| December 31, 2003 | 583.16M |
| December 31, 2002 | 634.98M |
| December 31, 2001 | 743.20M |
| December 31, 2000 | 459.92M |
| December 31, 1999 | 187.80M |
| December 31, 1998 | 24.20M |
| December 31, 1997 | 71.50M |
| December 31, 1996 | 34.90M |
| December 31, 1995 | 28.40M |
| December 31, 1994 | 71.60M |
| December 31, 1993 | 28.60M |
| December 31, 1992 | 11.60M |
| December 31, 1991 | 27.60M |
| December 31, 1990 | 4.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
3.808B
Minimum
2019
11.22B
Maximum
2023
7.998B
Average
7.525B
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Amgen Inc | 10.94B |
| Eli Lilly and Co | 2.928B |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Alpine Immune Sciences Inc | 327.41M |
| Editas Medicine Inc | 323.11M |